CMA expands probe of pharmaceutical sector

The UK’s antitrust agency last week opened three more investigations into alleged anticompetitive agreements in the pharmaceutical sector, expanding the agency’s already extensive probe of the market.

Get unlimited access to all Global Competition Review content